Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 5744 Lung Neoplasms 3716 Small Cell Lung Carcinoma 1017 Breast Neoplasms 667 Neoplasms 616 Colorectal Neoplasms 556 Melanoma 479 Ovarian Neoplasms 434 Neoplasm Metastasis 431 Pancreatic Neoplasms 386 Stomach Neoplasms 332 Carcinoma, Renal Cell 311 Adenocarcinoma of Lung 308 Squamous Cell Carcinoma of Head and Neck 304 Head and Neck Neoplasms 293 Prostatic Neoplasms 284 Mesothelioma, Malignant 281 Esophageal Neoplasms 265 Mesothelioma 244 Colonic Neoplasms 225 Brain Neoplasms 216 Urinary Bladder Neoplasms 212 Triple Negative Breast Neoplasms 209 Uterine Cervical Neoplasms 207 Endometrial Neoplasms 174 Sarcoma 171 Carcinoma, Hepatocellular 158 NSCLC 134 Kidney Neoplasms 127 Carcinoma 127

Interventions

adagrasib 1 Nivolumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Resectable Non-Small Cell Lung Cancer × Thoracic × Clear all

NCT05472623 2025-09-15

Neo-Kan

Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins

Phase 2 Withdrawn

Resectable Non-Small Cell Lung Cancer

Data powered by HemOnc (CC BY 4.0) Colophon ⚡